Marshall Wace Asia’s ResMed RMD Stock Holding History

Marshall Wace Asia’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,405	Closed	-$3.68M	–	133
2019 Q1	$3.68M	Buy	+35,405	New	+$3.65M	0.11%	71

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace Asia's RMD Position: Q2 2019 in Review

Marshall Wace Asia sold out of ResMed (RMD) in Q2 2019, closing a stake of 35,405 shares — an estimated $3.68M sold.

Marshall Wace Asia first reported a position in RMD in Q1 2019 and held it in 1 quarter. The position peaked at $3.68M in Q1 2019. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2019.

Marshall Wace Asia reported no remaining ResMed position as of Q2 2019 after selling out during the quarter.
Marshall Wace Asia sold 35,405 ResMed shares in Q2 2019, an estimated $3.68M.
Marshall Wace Asia first reported a position in ResMed in Q1 2019 and held it in 1 quarter.
Marshall Wace Asia's ResMed position peaked at $3.68M in Q1 2019.
485 funds tracked by Wall St. Rank held ResMed as of Q2 2019.

Based on Marshall Wace Asia's 13F filing for Q2 2019, filed 14 Aug 2019.